Characterisation and evaluation of pharmaceutical solvates of Atorvastatin calcium by thermoanalytical and spectroscopic studies

Chemistry Central Journal

Volumn 6, Issue 1, 2012, Pages

  Chadha, Renu ^a   Kuhad, Astha ^a   Arora, Poonam ^a   Kishor, Shyam ^b  

^a PANJAB UNIVERSITY   (India)

^b Janta Vedic College Baraut   (India)

Author keywords

13C MAS solid state NMR; Calorimetry; Heat capacity; Recrystalliztion; Solvate

Indexed keywords

EID: 84866981477     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-6-114     Document Type: Article

References (22)

1. Othman A, Evans JSO, Evans IR, Harris RK, Hodgkinson P. Structural study of polymorphs and solvates of finasteride. J Pharm Sci 2007, 96:1380-1397. 10.1002/jps.20940, 17455354.
2. Griesser UJ. The importance of solvates. Polymorphism in the Pharmaceutical Industry 2006, 211-233. Weinheim, Germany: Viley-Vch Verlag GmbH & Co. KGaA, Hilfiker R.
3. Rustichellia C, Gamberini G, Feriolia V, Gamberinia MC, Ficarrab R, Tommasinic S. Solid state study of polymorphic drug: carbamazepine. J Pharm Biomed Anal 2000, 23:41-54. 10.1016/S0731-7085(00)00262-4, 10898153.
4. Tonder CV, Mahlatji MD, Malan SF, Liebenberg, Caira MR, Song M, Villiers MMD. Preparation and physicochemical characterization of 5 niclosamide solvates and 1 hemisolvate. AAPS Pharm Sci Tech 2004, 5:Article 12.
5. Chadha R, Arora P, Saini A, Singla ML, Jain DVS. Characterization of solvatomorphs of methotrexate using thermoanalytical and other techniques. Acta Pharm 2009, 59:245-247. 10.2478/v10007-009-0024-9, 19819822.
6. Jin YS, Ulrich J. New Crystalline Solvates of Atorvastatin Calcium. Chem Eng Tech 2010, 33(5):839-44.
7. Grünenberg A. Solid form analysis with special consideration of perfusion calorimetry PhD thesis 1997, Polymorphie und thermische Analyse pharmazeutischer Wirkstoffe. Pharmazie in unserer Zeit.
8. SohnY T. Effect of crystal form on bioavailability. J Korean Pharm Sci 2004, 34:443-452.
9. Sohn YT. Crystal forms of an angiotensin II receptor antagonist BR-A657. J Therm Anal Calori 2007, 89:799-802.
10. SohnY T, Lee YH. Polymorphism of doxazosin mesylate. Arch Pharm Res 2005, 28:730-735. 10.1007/BF02969365, 16042084.
11. Khankari RK, Grant DJW. Pharmaceutical hydrates. Thermochimica Acta 1995, 24E:61-79.
12. Ghugare P, Dongre V, Karmuse P. Structural Study of Polymorphs and Solvates of Finasteride. J Pharm Biomed Anal 2009, 51:532-540.
13. Shete G, Puri V, Bansal AK. Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples. AAPS PharmSciTech 2010, 11:598-609. 10.1208/s12249-010-9419-7, 2902319, 20352531.
14. Henwood SQ, Liebenberg W, Lourens R, Villiers M. Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates and hydrates. Drug Devel Ind Pharm 2001, 27:1017-1030.
15. Ghugaree P, Dongre V, Karmuse P, Rana R, Singh D, Kumar A, Filmwala Z. Solid-state investigation and characterization of the polymorphic and pseudopolymorphic forms of indpamide. J Pharm Biomed Anal 2009, 51:532-540.
16. Caira MR, Bettinetti G, Sorrenti M, Catenacci L. Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of Brodimoprim. J Pharm Sci 2007, 96:996-1007. 10.1002/jps.20934, 17455357.
17. Masuda K, Tabata S, Kono H, Sakata Y, Hayase T, Yonemochi E, Terada K. Solid-state 13C NMR study of indomethacin polymorphism. Int J Pharmaceutics 2006, 318:146-153.
18. Park JS, Kang SJ, Kim CK. Use of CP/MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms. E J Pharmaceutics and Biopharmaceutics 2005, 60:407-412.
19. Stephenson GA, Stowell JG, Toms PH, Dorman DE, Greene JR, Byrn SR. Solid-state Analysis of polymorphic, isomorphic, and solvated forms of dirithromycin. J Am Chem Soc 1994, 116:5766-5773.
20. Stephenson GA, Stowell JG, Toms PH, Pfeiffer RR, Byrn SR. Solid-state investigations of erythromycin A dehydrate: structure, NMR spectroscopy, and hygroscopy. J Pharm Sci 1997, 86:1239-1244. 10.1021/js9701667, 9383733.
21. Caira MR, Bettinetti G, Sorrenti M. Structural relationships, thermal properties and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim. J Pharm Sci 2002, 91:467-481. 10.1002/jps.10034, 11835206.
22. Guideline for Residual Solvents International Conference on Harmonization of Technical Requirements for registration of Pharmaceuticals for Human Use, ICH Q3 impurites July 1997, Geneva, Switzerland, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q3C/Step4/Q3C_R5_Step4.pdf, Guideline for Residual Solvents.